Phio Pharmaceuticals Corp. (PHIO) Financials

PHIO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 9.5 million 2.3 million
2023-06-30 12.3 million 2.4 million
2023-03-31 9.7 million 2.4 million
2022-12-31 12.8 million 2.0 million

PHIO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.9 million 89000
2023-06-30 -2.8 million 94000
2023-03-31 -2.7 million 111000
2022-12-31 -2.8 million 42000

PHIO Net Income

No data available :(

PHIO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 8.4 million - 70000
2023-06-30 11.3 million - 104000
2023-03-31 9.0 million - 138000
2022-12-31 11.8 million - 170000

PHIO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 2.4 million
2023-06-30 1.7 million
2023-03-31 1.1 million
2022-12-31 1.1 million

PHIO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 1.8 million 968000 -
2023-06-30 5000 1.4 million 1.2 million -
2023-03-31 5000 2.1 million 1.5 million -
2022-12-31 114000 1.6 million 1.1 million -

PHIO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 47000
2023-06-30 - 47000
2023-03-31 - 47000
2022-12-31 - 46000

PHIO

Price: $0.82

52 week price:
0.50
12.27

Earnings Per Share: -5.20 USD

P/E Ratio: -0.08

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 90800

Market Capitalization: 3.1 million

Links: